MED7 anticorps (C-Term)
Aperçu rapide pour MED7 anticorps (C-Term) (ABIN3073337)
Antigène
Voir toutes MED7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- Cofactor Required for Sp1 Transcriptional Activation Subunit 9 (CRSP9, Activator Recruited Cofactor 34kD Component, ARC34, CRSP33, MED7, MGC12284, RNA Polymerase Transcriptional Regulation Mediator Subunit 7 Homolog, Transcriptional Coactivator CRSP33)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- Synthetic peptide corresponding to the C-terminal region of human CRSP9
-
Isotype
- IgG2b
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.4, 1 % BSA and 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- MED7 (Mediator Complex Subunit 7 (MED7))
-
Autre désignation
- Cofactor Required For Sp1 Transcriptional Activation Subunit 9
-
Pathways
- Stem Cell Maintenance, Regulation of Lipid Metabolism by PPARalpha
Antigène
-